Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas

13 Nov 2018

Abstract excerpt

BACKGROUND: Uterine leiomyomas (ULs) are the most common gynecologic tumors and affect 3 of every 4 women by the age of 50 years. The majority of ULs are classified as conventional tumors, whereas 10% represent various histopathological subtypes with features that mimic malignancy. These subtypes include cellular and mitotically active ULs and ULs with bizarre nuclei. Uterine leiomyosarcoma (ULMS), the malignant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microtubule and mitosis dynamics
Share to Telomeres, Telomerase, and Senescence
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30423196
DOI: 10.1002/cncr.31754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomasPMID 30423196Read ↗

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12Semantic proximity Read ↗

Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcomaSemantic proximity Read ↗

Leiomyosarcoma With Alternative Lengthening of Telomeres Is Associated With Aggressive Histologic Features, Loss of ATRX Expression, and Poor Clinical OutcomeSemantic proximity Read ↗

Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas (Review)Semantic proximity Read ↗

Differential nuclear ATRX expression in sarcomas.Semantic proximity Read ↗

Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.Semantic proximity Read ↗

Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient BenefitSemantic proximity Read ↗

[Values of ATRX protein expression and ALT activation in differential diagnosis of uterine leiomyosarcoma].Semantic proximity Read ↗

ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomasSemantic proximity Read ↗

ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic SarcomasSemantic proximity Read ↗

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaSemantic proximity Read ↗

Integrative genomic and transcriptomic analysis of leiomyosarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.